000 01159 a2200349 4500
005 20250511151853.0
264 0 _c19770331
008 197703s 0 0 eng d
022 _a0022-3050
024 7 _a10.1136/jnnp.39.12.1219
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTeychenne, P F
245 0 0 _aNomifensine in parkinsonism.
_h[electronic resource]
260 _bJournal of neurology, neurosurgery, and psychiatry
_cDec 1976
300 _a1219-21 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAged
650 0 4 _aClinical Trials as Topic
650 0 4 _aDyskinesia, Drug-Induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsoquinolines
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParkinson Disease
_xdrug therapy
700 1 _aPark, D M
700 1 _aFindley, L J
700 1 _aRose, F C
700 1 _aCalne, D B
773 0 _tJournal of neurology, neurosurgery, and psychiatry
_gvol. 39
_gno. 12
_gp. 1219-21
856 4 0 _uhttps://doi.org/10.1136/jnnp.39.12.1219
_zAvailable from publisher's website
999 _c806389
_d806389